NeuroScientific Biopharmaceuticals Limited (ASX:NSB)
Australia · Delayed Price · Currency is AUD 0.1150
0.00 (0.00%)
Apr 17, 2026, 2:09 PM AEST
ASX:NSB Market Cap
ASX:NSB has a market cap or net worth of 38.25 million as of April 17, 2026. Its market cap has increased by 545.09% in one year.
Market Cap
38.25M
Enterprise Value
31.89M
Revenue
317.91K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.12
Market Cap Chart
Since July 27, 2018, ASX:NSB's market cap has increased from 16.56M to 38.25M, an increase of 131.02%. That is a compound annual growth rate of 11.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 38.25M | 4.55% |
| Dec 31, 2025 | 36.58M | 666.63% |
| Dec 30, 2024 | 4.77M | -25.00% |
| Dec 29, 2023 | 6.36M | -64.52% |
| Dec 29, 2022 | 17.93M | -62.69% |
| Dec 31, 2021 | 48.06M | 116.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Radiopharm Theranostics | 70.88M |
| Neurizon Therapeutics | 60.61M |
| Imugene | 55.34M |
| Prescient Therapeutics | 54.68M |
| Entropy Neurodynamics | 45.28M |
| Proteomics International Laboratories | 41.30M |
| EZZ Life Science Holdings | 37.65M |
| Avecho Biotechnology | 34.90M |